Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entity represents a *pseudogene version* of the **tubulin alpha 1b** gene. Unlike the protein-coding **TUBA1B** gene, which encodes a cytoskeletal protein involved in microtubule function and is studied in the context of cancer immunology and cell cycle regulation[1][3], **tubulin, alpha 1b pseudogene** does not code for a functional protein[3]. Pseudogenes are remnants of genes that have lost their ability to encode proteins due to mutations or truncations and are *not considered therapeutic targets*. Important clarification: - The **functional gene** is **TUBA1B** (*tubulin alpha 1b*), which is a cytoskeletal component involved in microtubule formation, cell division, and is implicated in the prognosis of several cancers[1][3]. - **ENSG00000249729 / LOC100419045** is specifically labeled as a "pseudogene" and does not produce a functional protein[3]. - As a pseudogene, it cannot be targeted by drugs or act as a receptor, enzyme, or transporter. Summary: The "tubulin, alpha 1b pseudogene" (ENSG00000249729) is not a functional nor druggable target; all physiological and disease relevance is tied to the protein-coding **TUBA1B** gene, not to this pseudogene[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin alpha 1b pseudogene.